Diabetes drugs tested as shield for kidneys during heart scans
NCT ID NCT07231939
Summary
This study looks at whether a common class of diabetes drugs, called SGLT2 inhibitors (flozins), can help prevent kidney injury caused by the contrast dye used during heart imaging and procedures. Researchers are reviewing the medical records of 4,000 patients who had these heart procedures to see if those taking the drugs had less kidney damage. The goal is to find a simple way to protect patients' kidneys during necessary medical tests.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Collegium Medicum w Bydgoszczy
RECRUITINGBydgoszcz, 85-094, Poland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.